M1 prime related biomarkers
Showing 1 - 25 of >10,000
HIV-1-infection Trial in New York, Philadelphia, Nashville (INO-6160, 2 mg, Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500
Recruiting
- HIV-1-infection
- INO-6160, 2 mg
- Trimer-4571 / 100 mcg 3M-052-AF (5 mcg) + Alum (500 mcg)
-
New York, New York
- +2 more
Apr 13, 2023
Quality of Life Trial in Cork (Riboflavin)
Recruiting
- Quality of Life
- Riboflavin
-
Cork, IrelandAtlantia Food Clinical Trials, 1st Floor, Block C, Heron House,
Mar 27, 2023
Geographic Atrophy Insights (i-GAIN) Natural History Study
Recruiting
- Dry Age-related Macular Degeneration
- +6 more
-
Belfast, United Kingdom
- +11 more
Mar 22, 2023
Quality of Life Trial in Cork (Vitamin C, )
Recruiting
- Quality of Life
- Vitamin C
- placebo
-
Cork, IrelandAtlantia Food Clinical Trials, 1st Floor, Block C, Heron House,
Feb 1, 2023
Survival Outcome for Severe Immune-related Hepatitis
Completed
- Lung Cancer
- PD-1/PD-L1 inhibitors
-
Changsha, Hunan, ChinaHunan Cancer hospital
May 13, 2022
Hepatopancreaticobiliary (HPB) Malignancy, Surgery Trial in Ottawa, Toronto (Active A, Active B, Lipid bolus)
Recruiting
- Hepatopancreaticobiliary (HPB) Malignancy
- Surgery
- Active A
- +3 more
-
Ottawa, Ontario, Canada
- +1 more
Jun 6, 2022
Visual Acuity Trial in Manchester (Acuvue® Oasys 1-Day)
Completed
- Visual Acuity
- Acuvue® Oasys 1-Day
-
Manchester, United KingdomThe University of Manchester
Jan 23, 2023
Biomarkers and Preeclampsia Outcomes
Completed
- Preeclampsia
-
Tunis, TunisiaMaternity Center of Tunis
Aug 19, 2022
COVID 19 Biomarkers
Recruiting
- COVID 19
- serum inflammatory biomarkers
-
Vancouver, British Columbia, CanadaVancouver General Hospital
Oct 31, 2022
Longer-term Respiratory Morbidity in Infants Born Extremely
Not yet recruiting
- Lung Function
- BPD - Bronchopulmonary Dysplasia
- Magnetic Resonance Imaging (MRI)
- +2 more
-
Ottawa, Ontario, Canada
- +3 more
Oct 3, 2023
HPV Infection, CIN1 Trial in Belgium, Estonia, United Kingdom (ChAdOx1-HPV, MVA-HPV, Placebo)
Active, not recruiting
- HPV Infection
- CIN1
- ChAdOx1-HPV
- +2 more
-
Antwerp, Belgium
- +15 more
Jan 9, 2023
Pain, Reward, Attention and Neurocircuitry: Biomarkers of
Recruiting
- Major Depressive Disorder
- +2 more
- No intervention
-
Toronto, Ontario, CanadaSakina Rizvi
Jul 27, 2022
Cardiovascular Toxicity: Comprehensive Myocardial and Vascular
Recruiting
- Cardiovascular Diseases
- +7 more
- Cardiovascular magnetic resonance with stress perfusion
- +4 more
-
London, United KingdomSt Bartholomews Hospital
Sep 15, 2023
Inflammatory Biomarkers of Pediatric Pulmonary Hypertension
Recruiting
- Hypertension, Pulmonary
- Blood test
-
Toronto, Ontario, Canada
- +1 more
May 17, 2022
HIV Vaccine, HIV-1-infection Trial in Chapel Hill, Durham (C62, C1C62, Placebo)
Recruiting
- HIV Vaccine
- HIV-1-infection
- C62
- +4 more
-
Chapel Hill, North Carolina
- +1 more
Oct 27, 2022
Diabetes Complications, Diabetes, Type 1, Diabetic Neuropathies Trial in Manchester (Hybrid Closed Loop Insulin Pump)
Not yet recruiting
- Diabetes Complications
- +2 more
- Hybrid Closed Loop Insulin Pump
-
Manchester, United KingdomManchester Diabetes Centre, Manchester University NHS Foundation
Jul 10, 2023
irAE Prediction of Anti-PD-1/L1 in Lung Cancer
Recruiting
- Immune Checkpoint Inhibitors
- Lung Cancer
-
Beijing, ChinaPeking Union Medical College Hospital
Mar 31, 2022
Age-Related Macular Degeneration Trial in Toronto (NG101 AAV gene therapy)
Not yet recruiting
- Age-Related Macular Degeneration
- NG101 AAV gene therapy
-
Toronto, Ontario, CanadaVitreous Retina Macula Specialists of Toronto
Aug 2, 2023
Validating Reward-related Biomarkers (RTOC)
Completed
- Schizophrenia
- +5 more
- Self-rating Questionnaires
- +2 more
-
Frankfurt, Germany
- +3 more
Jul 25, 2022
Diabetes, Type 1 Trial (Type 1 Diabetes and Life)
Not yet recruiting
- Diabetes Mellitus, Type 1
- Type 1 Diabetes and Life
- (no location specified)
Nov 14, 2022
Developmental Language Disorder, Language Delay, Language Development Trial in Oshawa, Toronto (Intervention to address late
Recruiting
- Developmental Language Disorder
- +2 more
- Intervention to address late talking
-
Oshawa, Ontario, Canada
- +1 more
Dec 4, 2023
Advanced Malignant Tumor, Metastatic Malignant Tumor, Recurrent Malignant Tumor Trial in Houston (Laboratory Biomarker Analysis,
Active, not recruiting
- Advanced Malignant Neoplasm
- +2 more
- Laboratory Biomarker Analysis
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2022
Novel MRI Biomarkers for Monitoring Disease Progression in ALS
Recruiting
- Amyotrophic Lateral Sclerosis
- Motor Neuron Disease
-
Miami, Florida
- +8 more
Jan 24, 2023
BEAM: Brain-Eye Amyloid Memory Study
Recruiting
- Alzheimer's Disease
- +4 more
- Pittsburgh Compound B [11C]-PIB
-
Toronto, Ontario, Canada
- +4 more
Oct 24, 2022
Patent Ductus Arteriosus After Premature Birth Trial in Hamilton, Toronto, Dublin (Acetaminophen Injection, Ibuprofen 20 mg/mL
Recruiting
- Patent Ductus Arteriosus After Premature Birth
- Acetaminophen Injection
- +2 more
-
Hamilton, Ontario, Canada
- +3 more
Jan 30, 2023